Ann: Notice of Investor Call and Presentation, page-101

Close, Bydureon is also long release. The purported difference is that PT320 gets to steady state faster~ 10 days vs. 35 days. I'm looking forward to hearing from Invex/Tom about any other superior differences about the PT320 formulation over Bydureon.

I'm sympathetic to shareholders that have expressed concern about the recent change in course from the company. This is a really complex area for retail investors, and the company didn't give investors the time to digest this announcement nor ask any questions. This isn't the first time that they've pulled a quick teleconference straight after an announcement - Jason did the same thing with the regulatory guidance announcement last year. Hence the Hotcopper meltdown as an outlet to vent for retail.